Agilisium Invests $5.5 Million in AI for Life Sciences

Agilisium, an AI services firm focused on the Life Sciences sector, has announced a substantial $5.5 million investment. This funding is earmarked to revolutionize how life science enterprises implement and operationalize artificial intelligence. The company is introducing a new category of experts, Forward Deployment Experts (FDX), to facilitate this transformation. This strategic investment aims to accelerate AI adoption and drive innovation within the pharmaceutical and biotechnology industries, enhancing operational efficiency and research capabilities.